Two Sigma Investments »

Travere Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $588k 500k 1.18

More positions owned by Two Sigma Investments

Western Digital Corp Note 3.000%11/1 (Principal)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Asml Hldg Nv N Y Registry Shs (ASML)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl A (GOOGL)
Citigroup Com New (C)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Boston Scientific Corporation (BSX)

View all positions for Two Sigma Investments

Top funds holding Travere Therapeutics

Ing Investment Management
BlackRock
Context Capital Management
Calamos Advisors
Polar Securities
Tenor Capital Management
Wellesley Investment Advisors
Lord, Abbett & Co
Lazard Asset Management
Steelhead Partners
M&G
Citadel Advisors
Ameriprise Financial
DeepCurrents Investment Group
D. E. Shaw & Co

View all funds holding Travere Therapeutics